经颅直流电刺激对卒中后疲劳患者的影响:双盲随机对照试验研究方案
本方案拟开展双盲随机对照试验,纳入100例卒中后疲劳患者,随机分为常规康复联合活性经颅直流电刺激组与常规康复联合伪刺激组,干预4周。主要结局为疲劳严重程度量表(FSS),次要结局包括FIS、FACIT-F和SS-QOL,并监测不良事件。
要点
- 纳入100例卒中后疲劳患者,随机分为活性经颅直流电刺激组与伪刺激组,均联合常规康复。
- 两组干预4周,经颅直流电刺激每天20分钟、每周6天。
- 主要结局为疲劳严重程度量表(FSS),次要结局为FIS、FACIT-F和SS-QOL。
核心结论
- 本研究旨在探讨经颅直流电刺激联合常规康复治疗卒中后疲劳的效果与安全性。
研究设计与样本
- 双盲随机对照试验,纳入100例卒中后疲劳患者,随机分为常规康复联合活性经颅直流电刺激组与常规康复联合伪刺激组。
- 两组均干预4周,经颅直流电刺激每天20分钟、每周6天。
- 主要结局为疲劳严重程度量表(FSS),于基线及干预期间每周末测量;次要结局为疲劳影响量表(FIS)、慢性病治疗功能评估-疲劳量表(FACIT-F)和卒中专用生活质量量表(SS-QOL),于基线及4周干预结束时测量。
- 整个研究期间每次治疗均监测不良事件和不良反应。
- 研究已获南昌大学第一附属医院伦理委员会批准(临床医学伦理审查[2015]043,2015年11月),并在中国临床试验注册中心注册(ChiCTR2000031120,2020年3月22日注册),方案版本号V1.1。
局限性
- 本研究为单中心试验,这可能是一个局限性。
- 本研究的另一个局限性是参与者数量相对较少,因此不能完全排除偶然因素对实验结果的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Post-stroke fatigue (PSF) is an abnormal, persistent, and unexplained physical and psychological tiredness in patients after stroke. It is a common symptom of stroke patients with poor quality of life and bleak prognosis, and the incidence rate is up to 39% to 72%. It has been widely reported that medicine treatments achieved a lot of progress, there still needs to develop more powerful new strategies to more powerful effect. The transcranial direct-current stimulation (tDCS) shows great potential for the treatment of PSF. This study proposes to apply a double-blind randomized controlled clinical trial to explore the effect and safety of tDCS combined with routine rehabilitation for PSF. METHODS AND ANALYSIS: One hundred patients with PSF will be randomly divided into two groups. One of the groups will receive conventional rehabilitation therapy and active tDCS, whereas another group will receive conventional rehabilitation treatment and sham tDCS. Both groups will receive the intervention for 4 weeks, during which time they will undergo either active or sham tDCS 20 min a day, 6 days a week. PRIMARY OUTCOME: Fatigue Severity Scale (FSS) will be measured at baseline every weekend during the intervention period. Secondary results: Fatigue Impact Scale (FIS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), and Specialized Quality of Life Scale in Stroke (SS-QOL) will be measured at baseline and at the end of the intervention time of 4 weeks. Throughout the study, adverse events and adverse reactions will be measured during every treatment. The research study "Effects of transcranial direct current stimulation on patients with post-stroke fatigue" has been approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University: Clinical Medicine Ethics Review [2015]043 in Nov 2015. DISCUSSION: This study will provide insight into the efficacy of transcranial direct-current stimulation for post-stroke fatigue. This is a double-blind randomized controlled trial whose aim is to assess the effects of tDCS on PSF. This study can provide more information about the treatment of PSF. This study has a period of follow-up, which allows for greater accuracy. It is a single-center trial, and this may be a limitation. The other limitation of this study is the relatively small number of participants; thus, the influence of chance on experimental results cannot be completely ruled out. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000031120 . Registered on March 22, 2020. This protocol version number is V1.1.
引用
- Sun X, Dong X, Yuan Q, et al. Effects of transcranial direct current stimulation on patients with post-stroke fatigue: a study protocol for a double-blind randomized controlled trial. Trials. 2022. PMID: 35248120. doi:10.1186/s13063-022-06128-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。